1990
DOI: 10.1016/0140-6736(90)92488-4
|View full text |Cite
|
Sign up to set email alerts
|

Non-inherited maternal HLA antigens and protection against serisitisation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
6
0

Year Published

1993
1993
2018
2018

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(6 citation statements)
references
References 16 publications
0
6
0
Order By: Relevance
“…However, many of these patients do not form antibodies to NIMH [47]. Subsequent repetitive antigen challenge may break this tolerance [48]. Tolerance to NIMH may in part be mediated by antiidiotypic antibodies [49].…”
Section: Discussionmentioning
confidence: 99%
“…However, many of these patients do not form antibodies to NIMH [47]. Subsequent repetitive antigen challenge may break this tolerance [48]. Tolerance to NIMH may in part be mediated by antiidiotypic antibodies [49].…”
Section: Discussionmentioning
confidence: 99%
“…18 However, the true existence of such tolerogenic "NIMA effect" has still been the subject of debate due to lack of the knowledge of the underlying immunologic mechanisms. 19,20 Recently, Andrassy et al have shown in a murine experimental model that more than half of the H-2 b/b offspring that had experienced both oral and in utero exposure to noninherited H-2 d antigens of semiallogenic H-2 b/d mothers could accept fully allogeneic H-2 d/d vascularized heart allografts for a long time. 21 Importantly, they also demonstrated that the tolerant mice had higher levels of maternal cell microchimerism after their birth as compared with the nontolerant mice, suggesting the role of long-term maternal microchimerism for the induction and maintenance of NIMA-specific allotolerance.…”
Section: Introductionmentioning
confidence: 99%
“…12 However, in a study of 140 patients with ESRD who were given donor-specific transfusions from donors who were mismatched for NIMA or NIPA, development of donor-specific anti-HLA antibody, rejection risk, and graft survival after kidney transplantation were similar between the 2 groups. 16 In contrast, retrospective analysis of 5000 paternal kidney transplant recipients using Collaborative Transplant Study data showed that paternal grafts had a superior 3-year graft survival compared with maternal grafts, a finding that has been corroborated by 1 other single-center study. 13,17 Our study has shown that maternal donor kidneys were associated with at least a 50% increased risk of acute rejection and multiple rejections, with the majority occurring within the first 6 months after transplantation.…”
Section: Discussionmentioning
confidence: 91%